- Home
- JTAI vs MTNB Comparison
JTAI vs MTNB Comparison
Compare JTAI & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JTAI
- MTNB
- Stock Information
- Founded
- JTAI 2018
- MTNB 2013
- Country
- JTAI United States
- MTNB United States
- Employees
- JTAI N/A
- MTNB N/A
- Industry
- JTAI Blank Checks
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- JTAI Finance
- MTNB Health Care
- Exchange
- JTAI Nasdaq
- MTNB Nasdaq
- Market Cap
- JTAI 8.3M
- MTNB 7.9M
- IPO Year
- JTAI N/A
- MTNB N/A
- Fundamental
- Price
- JTAI $3.19
- MTNB $1.88
- Analyst Decision
- JTAI Strong Buy
- MTNB Hold
- Analyst Count
- JTAI 1
- MTNB 1
- Target Price
- JTAI $11.00
- MTNB N/A
- AVG Volume (30 Days)
- JTAI 40.5K
- MTNB 1.4M
- Earning Date
- JTAI 08-15-2025
- MTNB 11-12-2025
- Dividend Yield
- JTAI N/A
- MTNB N/A
- EPS Growth
- JTAI N/A
- MTNB N/A
- EPS
- JTAI N/A
- MTNB N/A
- Revenue
- JTAI $12,790,684.00
- MTNB N/A
- Revenue This Year
- JTAI $13.37
- MTNB N/A
- Revenue Next Year
- JTAI $201.13
- MTNB N/A
- P/E Ratio
- JTAI N/A
- MTNB N/A
- Revenue Growth
- JTAI N/A
- MTNB N/A
- 52 Week Low
- JTAI $2.30
- MTNB $0.47
- 52 Week High
- JTAI $57.17
- MTNB $4.25
- Technical
- Relative Strength Index (RSI)
- JTAI 46.25
- MTNB 58.52
- Support Level
- JTAI $3.09
- MTNB $1.59
- Resistance Level
- JTAI $3.26
- MTNB $1.90
- Average True Range (ATR)
- JTAI 0.14
- MTNB 0.16
- MACD
- JTAI 0.00
- MTNB -0.04
- Stochastic Oscillator
- JTAI 30.95
- MTNB 44.48
About JTAI Jet.AI Inc.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as through Jet Token's leased and managed aircraft.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.